In both adult and pediatric VV- or VA-ECMO patients, soluble thrombomodulin levels did not differ between survivors and non-survivors [14,20], but increased in ECMO-supported respiratory failure patients with hemorrhagic complications compared to those without such complications [24]. The gene discussed is THBD; the disease is respiratory failure.